Filtered By:
Cancer: Cervical Cancer
Drug: Eloxatin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
ConclusionInhibition of E6 oncogene expression and subsequent E6-siRNA with Oxaliplatin combination therapy could be a novel strategy for cervical cancer treatment.Graphical Abstract
Source: European Journal of Medical Research - January 21, 2023 Category: Research Source Type: research
